A Sharing Tool For Next-Gen Sequencing: FDA Launches precisionFDA
This article was originally published in The Gray Sheet
As scheduled, FDA has launched its precisonFDA portal that the agency says will aggregate research data to help develop and verify next generation sequencing diagnostic tests.
You may also be interested in...
US FDA is challenging stakeholders to develop apps that users of its precisionFDA platform can leverage to advance next-generation sequencing technology. Results from the competition will be announced by Commissioner Robert Califf next month in Washington, DC.
As Bharat Biotech prepares its COVID-19 vaccine for a launch in the quarter ending next 30 September and claims at least 60% efficacy, questions arise over why trials were not temporarily halted following a serious adverse event during Phase I and why this wasn’t disclosed to participants in subsequent studies.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.